3-hydroxybutyric acid has been researched along with 2019 Novel Coronavirus Disease in 4 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Karagiannis, F | 1 |
Peukert, K | 1 |
Surace, L | 1 |
Michla, M | 1 |
Nikolka, F | 1 |
Fox, M | 1 |
Weiss, P | 1 |
Feuerborn, C | 1 |
Maier, P | 1 |
Schulz, S | 1 |
Al, B | 1 |
Seeliger, B | 1 |
Welte, T | 1 |
David, S | 1 |
Grondman, I | 1 |
de Nooijer, AH | 1 |
Pickkers, P | 1 |
Kleiner, JL | 1 |
Berger, MM | 1 |
Brenner, T | 1 |
Putensen, C | 1 |
Kato, H | 1 |
Garbi, N | 1 |
Netea, MG | 1 |
Hiller, K | 1 |
Placek, K | 1 |
Bode, C | 1 |
Wilhelm, C | 1 |
Hurtado, A | 1 |
Cano-Vicent, A | 1 |
Tuñón-Molina, A | 1 |
Aparicio-Collado, JL | 1 |
Salesa, B | 1 |
I Serra, RS | 1 |
Serrano-Aroca, Á | 1 |
Bolesławska, I | 1 |
Kowalówka, M | 1 |
Bolesławska-Król, N | 1 |
Przysławski, J | 1 |
Bradshaw, PC | 1 |
Seeds, WA | 1 |
Miller, AC | 1 |
Mahajan, VR | 1 |
Curtis, WM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
COVID-19 Vaccination in Subjects With Obesity: Impact of Metabolic Health and the Role of a Ketogenic Diet[NCT05163743] | 24 participants (Anticipated) | Interventional | 2021-05-23 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for 3-hydroxybutyric acid and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2-Review of the Evidence.
Topics: 3-Hydroxybutyric Acid; Animals; COVID-19; Diet, Ketogenic; Humans; Ketone Bodies; Mice; SARS-CoV-2 | 2023 |
COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm.
Topics: 3-Hydroxybutyric Acid; Adaptive Immunity; Animals; Betacoronavirus; Coronavirus Infections; COVID-19 | 2020 |
2 other studies available for 3-hydroxybutyric acid and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19.
Topics: 3-Hydroxybutyric Acid; Amino Acids; Animals; COVID-19; Diet, Ketogenic; Energy Metabolism; Esters; G | 2022 |
Engineering alginate hydrogel films with poly(3-hydroxybutyrate-co-3-valerate) and graphene nanoplatelets: Enhancement of antiviral activity, cell adhesion and electroactive properties.
Topics: 3-Hydroxybutyric Acid; Alginates; Antiviral Agents; Biocompatible Materials; Cell Adhesion; COVID-19 | 2022 |